{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:49Z","timestamp":1740123709023,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10689-021-00281-x","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:34:04Z","timestamp":1635172444000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of women at risk of hereditary breast\u2013ovarian cancer among participants in a population-based breast cancer screening"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-9630","authenticated-orcid":false,"given":"Luigina","family":"Bonelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Rebora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Biocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-6668","authenticated-orcid":false,"given":"Liliana","family":"Varesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"281_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10549-017-4274-9","volume":"164","author":"G Masala","year":"2017","unstructured":"Masala G, Ambrogetti D, Assedi M, Bendinelli B, Caini S, Palli D (2017) Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case-control study in the EPIC Florence cohort. Breast Cancer Res Treat 164:467\u2013473. https:\/\/doi.org\/10.1007\/s10549-017-4274-9","journal-title":"Breast Cancer Res Treat"},{"key":"281_CR2","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1002\/cam4.1427","volume":"7","author":"F Bravi","year":"2018","unstructured":"Bravi F, Decarli A, Russo AG (2018) Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study. Cancer Med 7:2145\u20132152. https:\/\/doi.org\/10.1002\/cam4.1427","journal-title":"Cancer Med"},{"key":"281_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/1055-9965.EPI-09-881","volume":"19","author":"LJ Martin","year":"2010","unstructured":"Martin LJ, Melnichouk O, Guo H, Chiarelli AM, Hislop TG, Yaffe MJ, Minkin S, Hopper JL, Boyd NF (2010) Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomark Prev 19:456\u2013463. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-881","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"281_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","volume":"3","author":"NJ Engmann","year":"2017","unstructured":"Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K (2017) Breast cancer surveillance consortium. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol 3:1228\u20131236. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6326","journal-title":"JAMA Oncol"},{"key":"281_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358:1389\u20131399. https:\/\/doi.org\/10.1016\/S0140-6736(01)06524-2","journal-title":"Lancet"},{"key":"281_CR6","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1158\/1055-9965.EPI-17-0531","volume":"26","author":"OO Shiyanbola","year":"2017","unstructured":"Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A (2017) Emerging trends in family history of breast cancer and associated risk. Cancer Epidemiol Biomark Prev 26:1753\u20131760. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0531","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"281_CR7","doi-asserted-by":"publisher","unstructured":"Hu C, Polley EC, Yadav S, Lilyquist J, Shimelis H, Na J, Hart SN, Goldgar DE, Shah S, Pesaran T, Dolinsky JS, LaDuca H, Couch FJ (2020) The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djaa023.","DOI":"10.1093\/jnci\/djaa023"},{"key":"281_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","volume":"322","author":"DK Owens","year":"2019","unstructured":"US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA 322:652\u2013665. https:\/\/doi.org\/10.1001\/jama.2019.10987","journal-title":"JAMA"},{"key":"281_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53:465\u2013471. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103672","journal-title":"J Med Genet"},{"key":"281_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejim.2016.03.010","volume":"32","author":"J Azzollini","year":"2016","unstructured":"Azzollini J, Scuvera G, Bruno E, Pasanisi P, Zaffaroni D, Calvello M, Pasini B, Ripamonti CB, Colombo M, Pensotti V, Radice P, Peissel B, Manoukian S (2016) Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: a monocentric Italian study. Eur J Intern Med 32:65\u201371. https:\/\/doi.org\/10.1016\/j.ejim.2016.03.010","journal-title":"Eur J Intern Med"},{"key":"281_CR11","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","volume":"372","author":"B Lauby-Secretan","year":"2015","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K (2015) Breast-cancer screening\u2014viewpoint of the IARC Working Group. N Engl J Med 372:2353\u20132358. https:\/\/doi.org\/10.1056\/NEJMsr1504363","journal-title":"N Engl J Med"},{"key":"281_CR12","unstructured":"Dimitrova N, Saz Parkinson Z, Bramesfeld A, Uluturk Tekin A, Bocchi G, Pylkkanen L, Lopez Alcalde J, Neamtiu L, Ambrosio M, Deandrea S, Lerda D (2016) European guidelines for breast cancer screening and diagnosis\u2014The European Breast Guidelines. EUR 28360 EN. Luxembourg (Luxembourg): Publications Office of the European Union. JRC104007"},{"key":"281_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"M Marmot","year":"2013","unstructured":"Marmot M, Altman D, Cameron D et al (2013) The benefits and harms of breast cancer screening: an independent review. Br J Cancer 108:2205\u20132240. https:\/\/doi.org\/10.1038\/bjc.2013.177","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"281_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1258\/jms.2012.012082","volume":"19","author":"Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E; EUROSCREEN Working Group","year":"2012","unstructured":"Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E; EUROSCREEN Working Group (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42\u201356. https:\/\/doi.org\/10.1258\/jms.2012.012082","journal-title":"J Med Screen"},{"key":"281_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33602","author":"JL Bulliard","year":"2021","unstructured":"Bulliard JL, Beau AB, Njor S, Wu WY, Procopio P, Nickson C, Lynge E (2021) Breast cancer screening and overdiagnosis. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.33602","journal-title":"Int J Cancer"},{"key":"281_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10552-010-9663-x","volume":"22","author":"JT Lowery","year":"2011","unstructured":"Lowery JT, Byers T, Hokanson JE, Kittelson J, Lewin J, Risendal B, Singh M, Mouchawar J (2011) Complementary approaches to assessing risk factors for interval breast cancer. Cancer Causes Control 22:23\u201331. https:\/\/doi.org\/10.1007\/s10552-010-9663-x","journal-title":"Cancer Causes Control"},{"key":"281_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10549-004-5168-1","volume":"90","author":"E Halapy","year":"2005","unstructured":"Halapy E, Chiarelli AM, Klar N, Knight JA (2005) Accuracy of breast screening among women with and without a family history of breast and\/or ovarian cancer. Breast Cancer Res Treat 90:299\u2013305. https:\/\/doi.org\/10.1007\/s10549-004-5168-1","journal-title":"Breast Cancer Res Treat"},{"key":"281_CR18","doi-asserted-by":"publisher","unstructured":"Blanch J, Sala M, Ib\u00e1\u00f1ez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Ru\u00e9 M, Salas D; INCA Study Group (2014). Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS ONE. 9(10):e110207. https:\/\/doi.org\/10.1371\/journal.pone.0110207.","DOI":"10.1371\/journal.pone.0110207"},{"key":"281_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/bjc.2016.56","volume":"114","author":"DG Evans","year":"2016","unstructured":"Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, Watterson D, Fox L, Sergeant JC, Ingham S, Harvie MN, Wilson M, Beetles U, Buchan I, Brentnall AR, French DP, Cuzick J, Howell A (2016) Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer 114:1045\u20131052. https:\/\/doi.org\/10.1038\/bjc.2016.56","journal-title":"Br J Cancer"},{"key":"281_CR20","unstructured":"TBST study group. Tailored screening for breast cancer in premenopausal women (TBST) https:\/\/clinicaltrials.gov\/ct2\/show\/ NCT02619123."},{"key":"281_CR21","unstructured":"My Pebs international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70. ClinicalTrials.gov Identifier: NCT03672331 http:\/\/www.MyPeBS.eu\/"},{"key":"281_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2824","author":"L Cortesi","year":"2020","unstructured":"Cortesi L, Baldassarri B, Ferretti S, Razzaboni E, Bella M, Bucchi L, Canuti D, De Iaco P, De Santis G, Falcini F, Galli V, Godino L, Leoni M, Perrone AM, Pignatti M, Saguatti G, Santini D, Sassoli de\u2019Bianchi P, Sebastiani F, Taffurelli M, Tazzioli G, Turchetti D, Zamagni C, Naldoni C (2020) A regional population-based hereditary breast cancer screening tool in Italy: first 5-year results. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.2824","journal-title":"Cancer Med"},{"key":"281_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2017.03.014","volume":"78","author":"A van Erkelens","year":"2017","unstructured":"van Erkelens A, Sie AS, Manders P, Visser A, Duijm LE, Mann RM, Ten Voorde M, Kroeze H, Prins JB, Hoogerbrugge N (2017) Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress. Eur J Cancer 78:45\u201352. https:\/\/doi.org\/10.1016\/j.ejca.2017.03.014","journal-title":"Eur J Cancer"},{"key":"281_CR24","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/j.clbc.2019.02.014","volume":"19","author":"K Wernke","year":"2019","unstructured":"Wernke K, Bellcross C, Gabram S, Ali N, Stanislaw C (2019) Impact of implementing B-RSTTM to screen for hereditary breast and ovarian cancer on risk perception and genetic counseling uptake among women in an academic safety net hospital. Clin Breast Cancer 19:e547\u2013e555. https:\/\/doi.org\/10.1016\/j.clbc.2019.02.014","journal-title":"Clin Breast Cancer"},{"key":"281_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195035681.001.0001","volume-title":"Clinical trials: design, conduct and analysis","author":"CL Meinert","year":"1986","unstructured":"Meinert CL (1986) Clinical trials: design, conduct and analysis. . Oxford University Press, Oxford"},{"key":"281_CR26","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.breast.2013.07.053","volume":"22","author":"L Varesco","year":"2013","unstructured":"Varesco L, Viassolo V, Viel A, Gismondi V, Radice P, Montagna M, Alducci E, Della Puppa L, Oliani C, Tommasi S, Caligo MA, Vivanet C, Zuradelli M, Mandich P, Tibiletti MG, Cavalli P, Lucci Cordisco E, Turchetti D, Boggiani D, Bracci R, Bruzzi P, Bonelli L (2013) Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics. Breast 22:1130\u20131135. https:\/\/doi.org\/10.1016\/j.breast.2013.07.053","journal-title":"Breast"},{"key":"281_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10897-016-0040-0","volume":"26","author":"A Kne","year":"2017","unstructured":"Kne A, Zierhut H, Baldinger S, Swenson KK, Mink P, Veach PM, Tsai ML (2017) Why is cancer genetic counseling underutilized by women identified as at risk for hereditary breast cancer? Patient perceptions of barriers following a referral letter. J Genet Couns 26:697\u2013715. https:\/\/doi.org\/10.1007\/s10897-016-0040-0","journal-title":"J Genet Couns"},{"key":"281_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clbc.2019.02.009","volume":"19","author":"E Silver","year":"2019","unstructured":"Silver E, Wenger N, Xie Z, Elashoff D, Lee K, Madlensky L, Trent J, Petruse A, Johansen L, Naeim A (2019) Implementing a population-based breast cancer risk assessment program. Clin Breast Cancer 19:246\u2013253","journal-title":"Clin Breast Cancer"},{"key":"281_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000489117","volume":"20","author":"M Krakow","year":"2017","unstructured":"Krakow M, Ratcliff CL, Hesse BW, Greenberg-Worisek AJ (2017) Assessing genetic literacy awareness and knowledge gaps in the US population: results from the health information national trends survey. Public Health Genomics 20:343\u2013348. https:\/\/doi.org\/10.1159\/000489117","journal-title":"Public Health Genomics"},{"key":"281_CR30","doi-asserted-by":"publisher","first-page":"E146","DOI":"10.5888\/pcd17.200257","volume":"17","author":"M Krakow","year":"2020","unstructured":"Krakow M, Rising CJ, Trivedi N, Yoon DC, Vanderpool RC (2020) Prevalence and correlates of family cancer history knowledge and communication among US adults. Prev Chronic Dis 17:E146. https:\/\/doi.org\/10.5888\/pcd17.200257","journal-title":"Prev Chronic Dis"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00281-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T07:19:16Z","timestamp":1655363956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00281-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00281-x","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}